Strategic Approach to Share Repurchase Program
dsm-firmenich, a leader in nutrition, health, and beauty innovations, has announced an ambitious share repurchase program aimed at optimizing capital structure and supporting its share-based compensation plans. This initiative is part of a broader strategy to enhance shareholder value while ensuring stability and growth for the future.
Announcement of the Share Repurchase Program
In an important release earlier this year, dsm-firmenich articulated its intention to repurchase ordinary shares with a total target valuation of €1 billion, starting with an initial commitment of €500 million. Commencing on April 1, 2025, the program's total aimed amount was adjusted to €580 million, which includes €80 million designated for share-based compensation commitments and €500 million allocated to reduce the company’s issued capital.
Recent Developments in Share Purchase
Reporting on the progress of this program, dsm-firmenich disclosed that a total of 216,266 shares were repurchased from April 7 to April 11 at an average cost of €85.88 per share, amounting to a total expenditure of €18.6 million.
As of now, the cumulative number of shares repurchased within this initiative stands at 349,669, with an average purchase price of €87.97. The total combined investment to date is €30.8 million, underscoring the company's proactive actions in managing capital effectively.
Future Plans and Expectations
Looking ahead, dsm-firmenich aims to complete this €580 million share repurchase by the end of a six-month timeframe from the program's inception. Additionally, the company has signaled plans for a subsequent €500 million share repurchase upon the completion of the strategic divestiture of its stake in the Feed Enzymes Alliance. This approach reflects the company's commitment to enhancing financial flexibility and shareholder value.
Company Insights and Impact
dsm-firmenich continues to leverage its innovative capabilities in nutrition, health, and beauty to create essential products and solutions catering to a global population. The strategic share repurchase is not only a financial maneuver but also a testament to their confident outlook on business growth and market positioning. Positioned on Euronext Amsterdam as Amsterdam:DSFIR, the company operates in almost 60 countries, reflecting its commitment to sustainability and value creation.
With its diverse workforce of nearly 30,000 employees, dsm-firmenich is focused on bringing continuous progress to life, catering to the needs of consumers worldwide.
Investor Communications and Support
For those interested in further details on dsm-firmenich’s share repurchase program or other business strategies, the investor relations team is readily available. They can be reached at investors@dsm-firmenich.com. For media inquiries, contact media@dsm-firmenich.com.
Frequently Asked Questions
What is the purpose of dsm-firmenich's share repurchase program?
The share repurchase program aims to optimize capital structure, support share-based compensation plans, and enhance shareholder value.
How much is dsm-firmenich planning to invest in the share repurchase program?
dsm-firmenich intends to invest a total of €1 billion, with an initial €580 million allocated for the current phase of the program.
When is the deadline for the share repurchase program?
The program will be completed no later than six months from its start date in April 2025.
How many shares have been repurchased so far?
As of now, 349,669 shares have been repurchased under this initiative, amounting to a total investment of €30.8 million.
How can investors get more information?
Investors can contact the dsm-firmenich investor relations team at investors@dsm-firmenich.com for detailed inquiries.
